Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Hanel

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|May 16, 2022
Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell DyscrasiasZachary Braunstein, Eric McLaughlin, Miguel Ruiz, et al.
Hematological Oncology|August 4, 2021
Impact of initial chemotherapy regimen on outcomes for patients with double-expressor lymphoma: A multi-center analysisChristopher R D'Angelo, Walter Hanel, Yi Chen, et al.
Experimental Hematology & Oncology|July 13, 2022
A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cellsWalter Hanel, Pushpa Lata, Youssef Youssef, et al.
Cancers|March 11, 2023
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's LymphomaWalter Hanel, Polina Shindiapina, David A Bond, et al.
Journal of Hematology & Oncology|March 18, 2025
Second primary malignancies following CAR T-cell therapy in patients with hematologic malignanciesElvira Umyarova, Charles Pei, William Pellegrino, et al.
Blood Advances|August 30, 2024
Evaluation of prognostic factors in patients with high-risk classical Hodgkin lymphoma undergoing autologous transplantationNarendranath Epperla, Ying Huang, Amanda F Cashen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2025
The novel immunocompetent Eµ-SOX11CCND1 mouse model phenotypically and molecularly resembles human mantle cell lymphomaHedieh Jafari, Fiona Brown-Burke, Betsy Pray, et al.
Blood|June 2, 2023
PRMT5 supports multiple oncogenic pathways in mantle cell lymphomaShelby L Sloan, Fiona Brown, Mackenzie Long, et al.
Haematologica|October 15, 2020
Transducin β-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphomaYoussef Youssef, Vrajesh Karkhanis, Wing Keung Chan, et al.
American Journal of Hematology|January 2, 2023
Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective studyBrian T Hess, Anshu Giri, Yeonhee Park, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|May 16, 2022
Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell DyscrasiasZachary Braunstein, Eric McLaughlin, Miguel Ruiz, et al.
Hematological Oncology|August 4, 2021
Impact of initial chemotherapy regimen on outcomes for patients with double-expressor lymphoma: A multi-center analysisChristopher R D'Angelo, Walter Hanel, Yi Chen, et al.
Experimental Hematology & Oncology|July 13, 2022
A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cellsWalter Hanel, Pushpa Lata, Youssef Youssef, et al.
Cancers|March 11, 2023
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's LymphomaWalter Hanel, Polina Shindiapina, David A Bond, et al.
Journal of Hematology & Oncology|March 18, 2025
Second primary malignancies following CAR T-cell therapy in patients with hematologic malignanciesElvira Umyarova, Charles Pei, William Pellegrino, et al.
Blood Advances|August 30, 2024
Evaluation of prognostic factors in patients with high-risk classical Hodgkin lymphoma undergoing autologous transplantationNarendranath Epperla, Ying Huang, Amanda F Cashen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2025
The novel immunocompetent Eµ-SOX11CCND1 mouse model phenotypically and molecularly resembles human mantle cell lymphomaHedieh Jafari, Fiona Brown-Burke, Betsy Pray, et al.
Blood|June 2, 2023
PRMT5 supports multiple oncogenic pathways in mantle cell lymphomaShelby L Sloan, Fiona Brown, Mackenzie Long, et al.
Haematologica|October 15, 2020
Transducin β-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphomaYoussef Youssef, Vrajesh Karkhanis, Wing Keung Chan, et al.
American Journal of Hematology|January 2, 2023
Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective studyBrian T Hess, Anshu Giri, Yeonhee Park, et al.
Pageof 5